Although p73 was first shown to induce apoptosis in cancer cells about a decade ago, there has not been much progress in developing therapeutics that selectively target the tumor suppressor. Researchers recently described in The Journal of Clinical Investigation what they said is the first strategy to directly and selectively activate p73. The authors believe this mechanism could be used to develop drugs that will treat a broad range of